_treating-ibd-immunomodulators-preview-1.jpg "Treating IBD: Immunomodulators from immunomodulatory therapy Video Screenshot Preview 1")
Gallery_treating-ibd-immunomodulators-preview-3.jpg "Treating IBD: Immunomodulators from immunomodulatory therapy Video Screenshot Preview 3")
Gallery_treating-ibd-immunomodulators-preview-hqdefault.jpg "Treating IBD: Immunomodulators from immunomodulatory therapy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 11 seconds
👁 View: 5.1K times
Play Audio:👁 View: 5.1K times
Description:
Crohn's u0026 Colitis Foundation
Crohn's u0026 Colitis Foundation
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_immunomodulators-part-1-immunosuppressants.webp "Professor Dave Explains")
_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs.webp "PromoCell")
⏲ 2 minutes 26 seconds 👁 1.8K
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.webp "Can Probiotics Really Treat Lactational Mastitis? nLactational mastitis is an infection of one or more lobules of the mammary gland, occurring up to 33% of lactating mothers. Although the condition may happen at any point during the lactation period, between 75-95% of cases occur within the first 12 weeks, with the frequency particularly higher during the second and third weeks postpartum. nnNew research shows that lactational mastitis is a dysbiotic process. Significant levels of beneficial mic")
_immunomodulatory-drugs.webp "Myeloma UK")
_ido1-indoleamine-23-dioxygenase.webp "IDO1 is an immunosuppressive enzyme that leads to regulatory T-cell generation and activation, and allows tumors to escape from immune surveillance.nnInhibition of immunomodulatory mechanisms with IDO1 inhibitor-based combination therapy may re-establish anti-tumor immunity.")
_the-imsavar-project-making-immunomodulatory-therapies-safer.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_immunomodulators-part-2-immunostimulants.webp "Professor Dave Explains")
_what-should-you-know-about-myeloma-treatment-options.webp "Dr. Peter Forsberg outlines options in the myeloma treatment toolkit, including targeted therapies, chemotherapy, immunotherapy, and combination approaches —and explains how the recovery process from stem cell transplant has improved.nnDr. Peter Forsberg is assistant professor of medicine at the University of Colorado School of Medicine and is a specialist in multiple myeloma. More about Dr. Forsberg here: https://www.cudoctors.com/Find_A_Doctor/Profile/24672.")
_immunomodulators-part-1-immunosuppressants.jpg)
_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs.jpg)
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.jpg)
_immunomodulatory-drugs.jpg)
_ido1-indoleamine-23-dioxygenase.jpg)
_the-imsavar-project-making-immunomodulatory-therapies-safer.jpg)
_immunomodulators-part-2-immunostimulants.jpg)
_what-should-you-know-about-myeloma-treatment-options.jpg)
![[+]](/images/menu.gif){kind=small}